Log on/register
BioMed Central home | Journals A-Z | Feedback | Support | My details
 
Open AccessHighly AccessResearch

The script concordance test in radiation oncology: validation study of a new tool to assess clinical reasoning

Carole Lambert1,2 email, Robert Gagnon1 email, David Nguyen2 email and Bernard Charlin1 email

CPASS, Faculty of Medicine, University of Montreal, CP 6128, Succursale Centre-Ville, Montreal, Quebec, H3C 3J7, Canada

CHUM (Centre Hospitalier de l'Université de Montréal), Notre-Dame Hospital, radiation oncology department, 1560 Sherbrooke East, Montreal, Quebec, H2L 4M1, Canada

author email corresponding author email

Radiation Oncology 2009, 4:7doi:10.1186/1748-717X-4-7

Published: 9 February 2009

Abstract

Background

The Script Concordance test (SCT) is a reliable and valid tool to evaluate clinical reasoning in complex situations where experts' opinions may be divided. Scores reflect the degree of concordance between the performance of examinees and that of a reference panel of experienced physicians. The purpose of this study is to demonstrate SCT's usefulness in radiation oncology.

Methods

A 90 items radiation oncology SCT was administered to 155 participants. Three levels of experience were tested: medical students (n = 70), radiation oncology residents (n = 38) and radiation oncologists (n = 47). Statistical tests were performed to assess reliability and to document validity.

Results

After item optimization, the test comprised 30 cases and 70 questions. Cronbach alpha was 0.90. Mean scores were 51.62 (± 8.19) for students, 71.20 (± 9.45) for residents and 76.67 (± 6.14) for radiation oncologists. The difference between the three groups was statistically significant when compared by the Kruskall-Wallis test (p < 0.001).

Conclusion

The SCT is reliable and useful to discriminate among participants according to their level of experience in radiation oncology. It appears as a useful tool to document the progression of reasoning during residency training.


© 1999-2010 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.